Enlivex Therapeutics Ltd.

ENLV - Company ID 0001596812

Market cap-

Rank-

Filings393

Enlivex Therapeutics Ltd. has filed 393 public company documents between 2014 and 2026. The most frequent type is 6-k (267 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchENLV overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut ENLV beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow ENLV via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	9y ago2017-02-24	2017-02-24	View filing
SC 13G/A	Passive ownership stake (update)	9y ago2017-02-14	-	View filing
6-K	6-K	9y ago2017-01-18	2017-01-18	View filing
SC 13G/A	Passive ownership stake (update)	9y ago2017-01-10	-	View filing
6-K	6-K	9y ago2016-11-29	2016-11-29	View filing
6-K	6-K	9y ago2016-10-24	2016-10-24	View filing
6-K	6-K	9y ago2016-09-12	2016-09-12	View filing
6-K	6-K	9y ago2016-08-25	2016-08-25	View filing
6-K	6-K	9y ago2016-08-09	2016-08-09	View filing
6-K	6-K	10y ago2016-07-05	2016-07-05	View filing
6-K	6-K	10y ago2016-06-23	2016-06-23	View filing
6-K	6-K	10y ago2016-06-09	2016-06-09	View filing
6-K	6-K	10y ago2016-05-25	2016-05-25	View filing
D	D	10y ago2016-04-01	-	View filing
S-8	Employee stock plan	10y ago2016-03-29	-	View filing
20-F	20-F	10y ago2016-03-29	2015-12-31	View filing
SC 13G	Passive ownership stake	10y ago2016-03-23	-	View filing
424B5	Prospectus supplement	10y ago2016-03-18	-	View filing
6-K	6-K	10y ago2016-03-18	2016-03-17	View filing
6-K	6-K	10y ago2016-03-17	2016-03-16	View filing
6-K	6-K	10y ago2016-03-16	2016-03-16	View filing
6-K	6-K	10y ago2016-02-24	2016-02-24	View filing
6-K	6-K	10y ago2016-02-23	2016-02-23	View filing
SC 13G/A	Passive ownership stake (update)	10y ago2016-02-12	-	View filing
6-K	6-K	10y ago2016-01-27	2016-01-27	View filing
6-K	6-K	10y ago2016-01-19	2016-01-19	View filing
6-K	6-K	10y ago2016-01-11	2016-01-11	View filing
6-K	6-K	10y ago2016-01-11	2016-01-11	View filing
6-K	6-K	10y ago2015-12-22	2015-12-22	View filing
6-K	6-K	10y ago2015-12-09	2015-12-09	View filing
6-K	6-K	10y ago2015-11-17	2015-11-17	View filing
6-K	6-K	10y ago2015-11-16	2015-11-16	View filing
6-K	6-K	10y ago2015-10-27	2015-10-27	View filing
6-K	6-K	10y ago2015-10-09	2015-10-09	View filing
6-K	6-K	10y ago2015-09-16	2015-09-16	View filing
6-K	6-K	10y ago2015-09-14	2015-09-14	View filing
6-K	6-K	10y ago2015-09-10	2015-09-10	View filing
6-K	6-K	10y ago2015-08-21	2015-08-21	View filing
EFFECT	EFFECT	10y ago2015-08-12	-	View filing
CORRESP	Company correspondence	10y ago2015-08-10	-	View filing
UPLOAD	SEC correspondence	10y ago2015-08-07	-	View filing
F-3	F-3	10y ago2015-08-03	-	View filing
6-K	6-K	11y ago2015-06-29	2015-06-29	View filing
6-K	6-K	11y ago2015-06-25	2015-06-25	View filing
6-K	6-K	11y ago2015-06-22	2015-06-22	View filing
6-K	6-K	11y ago2015-06-15	2015-06-15	View filing
6-K	6-K	11y ago2015-05-19	2015-05-19	View filing
6-K	6-K	11y ago2015-05-05	2015-05-05	View filing
6-K	6-K	11y ago2015-04-09	2015-04-09	View filing
6-K	6-K	11y ago2015-03-31	2015-03-31	View filing

Enlivex Therapeutics Ltd.

Similar companies to research next

Year